viscum obscurum/neoplasms

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2017/053429, filed Feb. 15, 2017, which claims benefit of European Application No. 16155735.0, filed Feb. 15, 2016, both of which are incorporated herein by reference in

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the treatment of Acquired Immune Deficiency Syndrome (AIDS) and other diseases or conditions where an individual's immune system is suppressed. More particularly, the present invention relates to

The invention relates to an antiviral agent comprising recombinant mistletoe lectins for treating virus infections, and to a medicinal drug and/or a pharmaceutical composition for treating virus infections. When virus infections occur, viruses penetrate the organism, where they replicate. The

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 8, 2016 is named 74062_0001_01_SL_ST25.txt and is 32,885 bytes in size. The invention

TECHNICAL FIELD The present invention relates to medicinally useful preparations derived from mistletoe, methods for making such preparations and treatment methods employing such preparations. More specifically, the invention relates to an orally ingestible preparation of mistletoe lectins useful in

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 8, 2016 is named 74062_0002_01_SL_ST25.txt and is 33,022 bytes in size. The invention

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the treatment of Acquired Immune Deficiency Syndrome (AIDS) and other diseases or conditions where an individual's immune system is suppressed. More particularly, the present invention relates to

FIELD OF THE INVENTION The present invention relates generally to the preparation of mistletoe extracts and methods for making such extracts in a medicinally useful and pharmaceutically acceptable form. More particularly, the present invention relates to methods for making and using mistletoe

FIELD OF THE INVENTION The present invention relates, in general, to a crude extract from Viscum album coloratum and proteins and lectins isolated therefrom. More particularly, the present invention relates to an extract from Viscum album coloratum which enhances biological immunity with antitumoral